Laraway Financial Advisors’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.42M Sell
7,900
-200
-2% -$60.7K 2.08% 12
2026
Q1
$1.73M Sell
8,100
-1,000
-11% -$224K 1.22% 22
2025
Q4
$1.56M Sell
9,100
-100
-1% -$15.6K 1.01% 26
2025
Q3
$1.23M Buy
9,200
+200
+2% +$21.2K 0.84% 32
2025
Q2
$876K Hold
9,000
0.66% 40
2025
Q1
$654K Sell
9,000
-100
-1% -$7.88K 0.52% 48
2024
Q4
$657K Sell
9,100
-100
-1% -$7.58K 0.51% 51
2024
Q3
$751K Sell
9,200
-100
-1% -$8.69K 0.6% 45
2024
Q2
$990K Hold
9,300
0.85% 34
2024
Q1
$904K Sell
9,300
-10
-0.1% -$880 0.8% 35
2023
Q4
$729K Hold
9,310
0.69% 43
2023
Q3
$584K Hold
9,310
0.61% 51
2023
Q2
$599K Hold
9,310
0.59% 51
2023
Q1
$494K Hold
9,310
0.5% 65
2022
Q4
$391K Buy
9,310
+10
+0.1% +$418 0.41% 76
2022
Q3
$340K Sell
9,300
-200
-2% -$8.9K 0.38% 77
2022
Q2
$403K Sell
9,500
-1,100
-10% -$52.4K 0.43% 72
2022
Q1
$567K Sell
10,600
-100
-0.9% -$5.82K 0.52% 64
2021
Q4
$766K Buy
+10,700
New +$671K 0.68% 48

Other funds holding LRCX

Laraway Financial Advisors's LRCX Position: Q2 2026 in Review

Laraway Financial Advisors reduced its Lam Research (LRCX) stake by 2.5% in Q2 2026, selling an estimated $60.7K and leaving 7,900 shares worth $3.42M. The position accounts for 2.08% of the portfolio, ranked #12.

Laraway Financial Advisors first reported a position in LRCX in Q4 2021 and has held it in 19 quarters since. 3,135 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

  • Laraway Financial Advisors held 7,900 shares of Lam Research worth $3.42M as of Q2 2026.
  • Laraway Financial Advisors sold 200 Lam Research shares in Q2 2026, an estimated $60.7K.
  • Lam Research made up 2.08% of Laraway Financial Advisors's portfolio in Q2 2026, its #12 holding.
  • Laraway Financial Advisors first reported a position in Lam Research in Q4 2021 and has held it in 19 quarters since.
  • 3,135 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on Laraway Financial Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.